1. Home
  2. CTBI vs PHAT Comparison

CTBI vs PHAT Comparison

Compare CTBI & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Community Trust Bancorp Inc.

CTBI

Community Trust Bancorp Inc.

HOLD

Current Price

$63.57

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$11.42

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTBI
PHAT
Founded
1903
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
CTBI
PHAT
Price
$63.57
$11.42
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$59.00
$17.33
AVG Volume (30 Days)
50.7K
810.9K
Earning Date
04-22-2026
04-07-2026
Dividend Yield
3.33%
N/A
EPS Growth
5.73
N/A
EPS
3.92
N/A
Revenue
N/A
$55,252,000.00
Revenue This Year
$14.02
$221.87
Revenue Next Year
$4.30
$80.37
P/E Ratio
$16.22
N/A
Revenue Growth
N/A
8001.47
52 Week Low
$44.60
$2.21
52 Week High
$65.79
$18.31

Technical Indicators

Market Signals
Indicator
CTBI
PHAT
Relative Strength Index (RSI) 52.37 36.09
Support Level $61.94 $11.38
Resistance Level $65.18 $13.05
Average True Range (ATR) 1.58 0.80
MACD -0.30 -0.04
Stochastic Oscillator 40.23 13.81

Price Performance

Historical Comparison
CTBI
PHAT

About CTBI Community Trust Bancorp Inc.

Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and southcentral Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: